Should I Buy STTK? STTK 2026 Analysis

Should You Buy Shattuck Labs Inc (STTK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

4.070

1 Day change

-2.40%

52 Week Range

4.890

Analysis Updated At

2026/01/26

Shattuck Labs Inc (STTK) is not a strong buy for a beginner, long-term investor at this time. While there is insider buying and some bullish moving averages, the company's financial performance is weak, and the technical indicators do not suggest a strong upward trend. Additionally, the pre-market price is down 3.13%, and there are no significant positive catalysts or trading signals to support an immediate buy decision.

Technical Analysis

The MACD is negative and expanding (-0.074), indicating bearish momentum. The RSI is neutral at 39.387, and while moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the stock is trading below key pivot levels (Pivot: 4.481, Pre-market price: 4). Support levels are at 4.17 and 3.977, with resistance at 4.792 and 4.985.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Insiders are buying significantly, with a 6464.33% increase in buying activity over the last month. Moving averages are bullish.

Neutral/Negative Catalysts

The pre-market price is down 3.13%, and there are no recent news or significant analyst upgrades to drive sentiment.

Financial Performance

In Q3 2025, revenue dropped by 66.63% YoY to $1,000,000. Net income fell by 39.69% YoY to -$10,056,000, and EPS dropped by 57.58% YoY to -0.14. Gross margin remains stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Citi analyst Yigal Nochomovitz raised the price target from $2 to $4 but maintained a Neutral rating, indicating limited upside potential. There are no strong upgrades or bullish ratings from analysts.

4 Analyst Rating

Wall Street analysts forecast STTK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STTK is 5 USD with a low forecast of 4 USD and a high forecast of 6 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

2 Hold

0 Sell

Moderate Buy

Current: 4.170

Low

Averages

High

Current: 4.170

Low

Averages

High

Piper Sandler

Overweight

initiated

$15

AI Analysis

2026-01-28

New

Reason

Piper Sandler

Price Target

$15

AI Analysis

2026-01-28

New

initiated

Overweight

Reason

Piper Sandler initiated coverage of Shattuck Labs with an Overweight rating and $15 price target. The company's SL-325 offers a "differentiated approach" to treat inflammatory bowel disease patients where receptor blockade is expected to provide durable inflammation protection with a greater inhibitory effect, the analyst tells investors in a research note. Piper sees a high probability of success that SL-325 will show "clean" safety and tolerability. It recommends owning Shattuck ahead of the initial Phase 1 data in Q2.

Citi

Yigal Nochomovitz

Neutral

maintain

$2 -> $4

2026-01-06

Reason

Citi

Yigal Nochomovitz

Price Target

$2 -> $4

2026-01-06

maintain

Neutral

Reason

Citi analyst Yigal Nochomovitz raised the firm's price target on Shattuck Labs to $4 from $2 and keeps a Neutral rating on the shares. The firm sees opportunities in SMID-cap biotech heading into 2026 for commercial or near-commercial stage companies. As part of its 2026 outlook, Citi upgraded both Arvinas and Krystal Biotech while adding an "upside 90-day catalyst watch" on Olema Oncology.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for STTK

Unlock Now

STTK Should I Buy

STTK Should I Buy

Should You Buy Shattuck Labs Inc (STTK) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch